Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Deciphering the mechanism of action of antitubercular compounds with metabolomics. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1371/journal.ppat.0010005
10.1371/journal.ppat.0010005 · External reference
The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus
2017 · External reference
10.4084/mjhid.2013.070
10.4084/mjhid.2013.070 · External reference
Unresolved reference
External reference
Analysis of Approaches to Anti-tuberculosis Compounds
10.1021/acsomega.0c03177 · 2020 · External reference
Application of metabolomics to drug discovery and understanding the mechanisms of action of medicinal plants with anti-tuberculosis activity
10.1186/s40169-018-0208-3 · 2018 · External reference
Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling
10.1016/s1473-3099(19)30307-x · 2019 · External reference
10.1038/s41429-019-0205-9
10.1038/s41429-019-0205-9 · External reference
Practical biosafety in the tuberculosis laboratory: containment at the source is what truly counts
10.5588/ijtld.13.0629 · 2014 · External reference
Understanding Mass Spectrometry-based Global Mycobacterial Lipidomics
10.2174/1566524020666200206120840 · 2020 · External reference
Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates
10.1128/aac.06003-11 · 2012 · External reference
10.1016/j.tim.2017.05.007
10.1016/j.tim.2017.05.007 · External reference
10.1021/acs.accounts.0c00878
10.1021/acs.accounts.0c00878 · External reference
The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia
10.1371/journal.pone.0229040 · 2020 · External reference
First series of patients with XDR and pre-XDR TB treated with regimens that included meropenen-clavulanate in Argentina
10.1016/j.arbr.2015.07.003 · 2015 · External reference
Unresolved reference
External reference
Drug-Resistant Tuberculosis 2020: Where We Stand
10.3390/app10062153 · 2020 · External reference
NMR metabolomics and drug discovery
10.1002/mrc.2461 · 2009 · External reference
10.1016/j.tube.2019.03.003
10.1016/j.tube.2019.03.003 · External reference
Metabolite Profiling: A Tool for the Biochemical Characterisation of Mycobacterium sp
10.3390/microorganisms7050148 · 2019 · External reference
Nuclear magnetic resonance: a key metabolomics platform in the drug discovery process
10.1016/j.ddtec.2015.06.005 · 2015 · External reference
NMR Metabolomics Protocols for Drug Discovery
10.1007/978-1-4939-9690-2_16 · 2019 · External reference
Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824)
10.1038/s41598-018-23110-1 · 2018 · External reference
Early Drug Development and Evaluation of Putative Antitubercular Compounds in the -Omics Era
2021 · External reference
10.1021/jm401803b
10.1021/jm401803b · External reference
10.4155/tde.13.4
10.4155/tde.13.4 · External reference
High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds
10.1126/scitranslmed.aal3973 · 2018 · External reference
10.1517/17460441003631854
10.1517/17460441003631854 · External reference
Metabolomics in drug target discovery
10.1101/sqb.2011.76.010694 · 2011 · External reference
10.1038/nrd.2016.32
10.1038/nrd.2016.32 · External reference
Metabolomics in toxicology and preclinical research
10.14573/altex.2013.2.209 · 2013 · External reference
10.1007/978-1-4939-2450-9_6
10.1007/978-1-4939-2450-9_6 · External reference
Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine
10.3390/metabo10040129 · 2020 · External reference
Impact of approximately omics in the detection and validation of potential anti-infective drugs
10.1016/j.coph.2019.02.008 · 2019 · External reference
10.1016/j.tetlet.2015.02.129
10.1016/j.tetlet.2015.02.129 · External reference
10.1002/iub.1697
10.1002/iub.1697 · External reference
10.1001/jama.2020.1166
10.1001/jama.2020.1166 · External reference
10.1016/j.jacbts.2016.03.002 · Admitted local publication
The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development
10.1111/cts.12577 · 2018 · External reference
Applications of metabolomics in drug discovery and development
10.2165/00126839-200809050-00002 · 2008 · External reference
The application of mass spectrometry to proteomics and metabolomics in biomarker discovery and drug development
10.2174/1874467211205020301 · 2012 · External reference
Metabolomics as a tool for drug discovery and personalised medicine. A review
10.2174/1568026614666141215124956 · 2014 · External reference
Next-generation Metabolomics in the Development of New Antidepressants: Using Albiflorin as an Example
10.2174/1381612824666180727114134 · 2018 · External reference
10.1111/bph.13135
10.1111/bph.13135 · External reference
Advances in MS Based Strategies for Probing Ligand-Target Interactions: Focus on Soft Ionization Mass Spectrometric Techniques
10.3389/fchem.2019.00703 · 2019 · External reference
Discussion point: reporting guidelines for mass spectrometry imaging
10.1007/s00216-014-8322-6 · 2015 · External reference
10.1021/acs.analchem.5b00680
10.1021/acs.analchem.5b00680 · External reference
10.1002/anie.200906975
10.1002/anie.200906975 · External reference
10.1002/mas.21360
10.1002/mas.21360 · External reference
On-Tissue Derivatization via Electrospray Deposition for Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging of Endogenous Fatty Acids in Rat Brain Tissues
10.1021/acs.analchem.6b01021 · 2016 · External reference
10.7150/thno.45543
10.7150/thno.45543 · External reference
10.1002/rcm.8145
10.1002/rcm.8145 · External reference
Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study
10.1111/bph.12990 · 2015 · External reference
Precision pharmacology: Mass spectrometry imaging and pharmacokinetic drug resistance
10.1016/j.critrevonc.2019.06.008 · 2019 · External reference
10.1016/j.jprot.2012.02.011
10.1016/j.jprot.2012.02.011 · External reference
10.1002/rcm.4920
10.1002/rcm.4920 · External reference
10.1021/ac400009s
10.1021/ac400009s · External reference
High-throughput screening for drug discovery
1996 · External reference
High-throughput screening, metabolomics and drug discovery
2006 · External reference
10.1038/nrd941
10.1038/nrd941 · External reference
10.1016/j.celrep.2017.04.002
10.1016/j.celrep.2017.04.002 · External reference
10.1021/cb200348m
10.1021/cb200348m · External reference
10.1038/ncomms1562
10.1038/ncomms1562 · External reference
Quantitating metabolites in protein precipitated serum using NMR spectroscopy
10.1021/ac5005103 · 2014 · External reference
10.1073/pnas.1507743112
10.1073/pnas.1507743112 · External reference
Network integration and modelling of dynamic drug responses at multi-omics levels
10.1038/s42003-020-01302-8 · 2020 · External reference
Multi-omic data integration enables discovery of hidden biological regularities
10.1038/ncomms13091 · 2016 · External reference
10.1016/j.molcel.2019.04.001
10.1016/j.molcel.2019.04.001 · External reference
A comprehensive genome-scale reconstruction of Escherichia coli metabolism–2011
10.1038/msb.2011.65 · 2011 · External reference
Predicting and characterizing selective multiple drug treatments for metabolic diseases and cancer
10.1186/1752-0509-6-115 · 2012 · External reference
10.15252/msb.20156777
10.15252/msb.20156777 · External reference
10.1016/j.cell.2010.11.052
10.1016/j.cell.2010.11.052 · External reference
10.1371/journal.pone.0071403
10.1371/journal.pone.0071403 · External reference
A combined proteomics and metabolomics approach to assess the effects of gold nanoparticles in vitro
10.3109/17435390.2015.1121412 · 2016 · External reference
Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies
10.1074/mcp.m112.021683 · 2013 · External reference
Changes on proteomic and metabolomic profile in serum of mice induced by chronic exposure to tramadol
10.1038/s41598-021-81109-7 · 2021 · External reference
Application of metabolomics in toxicity evaluation of traditional Chinese medicines
10.1186/s13020-018-0218-5 · 2018 · External reference
The Opportunities of Metabolomics in Drug Safety Evaluation
10.1007/s40495-016-0079-5 · 2017 · External reference
Dose-Response Metabolomics To Understand Biochemical Mechanisms and Off-Target Drug Effects with the TOXcms Software
10.1021/acs.analchem.9b03811 · 2020 · External reference
A roadmap for the XCMS family of software solutions in metabolomics
10.1016/j.cbpa.2015.11.009 · 2016 · External reference
10.1371/journal.pone.0146021
10.1371/journal.pone.0146021 · External reference
10.1016/j.cmet.2018.06.002
10.1016/j.cmet.2018.06.002 · External reference
Minding the gaps: metabolomics mends functional genomics
10.1038/embor.2013.155 · 2013 · External reference
Metabolomics of Central Carbon Metabolism in Mycobacterium tuberculosis
10.1128/microbiolspec.mgm2-0026-2013 · 2014 · External reference
10.1016/j.tim.2011.03.008
10.1016/j.tim.2011.03.008 · External reference
10.1073/pnas.1907946116
10.1073/pnas.1907946116 · External reference
World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
2020 · External reference
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. Reply
10.1056/nejmoa1901814 · 2020 · External reference
Flexible nitrogen utilisation by the metabolic generalist pathogen Mycobacterium tuberculosis
10.7554/elife.41129 · 2019 · External reference
Lipidomic insights to understand membrane dynamics in response to vanillin in Mycobacterium smegmatis
10.1007/s10123-019-00099-9 · 2020 · External reference
10.1038/ncomms5306
10.1038/ncomms5306 · External reference
10.1074/mcp.ra118.000821
10.1074/mcp.ra118.000821 · External reference
Elucidating the antimicrobial mechanisms of colistin sulfate on Mycobacterium tuberculosis using metabolomics
10.1016/j.tube.2018.05.001 · 2018 · External reference
10.1126/science.aau8959
10.1126/science.aau8959 · External reference
First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform
10.1016/j.bbrc.2018.02.030 · 2018 · External reference
10.1016/j.chembiol.2014.09.002
10.1016/j.chembiol.2014.09.002 · External reference
10.1021/cr0783479
10.1021/cr0783479 · External reference
10.1039/b904091a
10.1039/b904091a · External reference
10.1039/c9sc03368h
10.1039/c9sc03368h · External reference
10.1039/c3cs60049a
10.1039/c3cs60049a · External reference
10.1021/acs.chemrev.0c01013
10.1021/acs.chemrev.0c01013 · External reference
Tracing Fatty Acid Metabolism by Click Chemistry
10.1021/cb300414v · 2012 · External reference
10.1038/s41592-019-0593-6
10.1038/s41592-019-0593-6 · External reference
Solid-Phase Enrichment and Analysis of Azide-Labeled Natural Products: Fishing Downstream of Biochemical Pathways
10.1002/chem.201503781 · 2016 · External reference
Deep Interrogation of Metabolism Using a Pathway-Targeted Click-Chemistry Approach
10.1021/jacs.0c06877 · 2020 · External reference
10.1111/2049-632x.12180
10.1111/2049-632x.12180 · External reference
Testing therapeutics in cell-based assays: factors that influence the apparent potency of drugs
10.1371/journal.pone.0194880 · 2018 · External reference
Insights into the physiology and metabolism of a mycobacterial cell in an energy-compromised state
10.1128/jb.00210-19 · 2019 · External reference
Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism
10.1038/ncomms4369 · 2014 · External reference
Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis
10.1038/s41429-020-0320-7 · 2020 · External reference
Application of distributive conjugal DNA transfer in Mycobacterium smegmatis to establish a genome-wide synthetic genetic array
10.1128/jb.00410-17 · 2017 · External reference
Comparative genome analyses of mycobacteria give better insights into their evolution
2017 · External reference
10.1016/j.chembiol.2009.04.001
10.1016/j.chembiol.2009.04.001 · External reference
Metabolomics analysis identifies D-Alanine-D-Alanine ligase as the primary lethal target of D-cycloserine in mycobacteria
10.1021/pr4010579 · 2014 · External reference
